Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Badley

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Experimental Medicine|January 6, 1997
Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factorA D Badley, D Dockrell, M Simpson, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitorA A Pilon, J J Lum, J Sanchez-Dardon, et al.
Clinical Pharmacology and Therapeutics|March 16, 2007
Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survivalS R Vlahakis, G D Bren, A Algeciras-Schimnich, et al.
Journal of Virology|January 1, 1996
Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytesA D Badley, J A McElhinny, P J Leibson, et al.
HIV Clinical Trials|October 9, 2001
Comparative CD4 T-cell responses of reverse transcriptase inhibitor therapy with or without nelfinavir matched for viral exposureS Kravcik, A Magill, B Sanghvi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2001
Effect of cessation of highly active antiretroviral therapy during a discordant response: implications for scheduled therapeutic interruptionsN Hawley-Foss, G Mbisa, J J Lum, et al.
AIDS Research and Human Retroviruses|December 2, 1999
Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy numberD H Dockrell, A D Badley, A Algeciras-Schimnich, et al.
Frontiers in Bioscience : a Journal and Virtual Library|February 10, 2004
Antiretroviral therapy influences cellular susceptibility to apoptosis in vivoCurtis L Cooper, Barbara Phenix, Georgina Mbisa, et al.
Cytometry|July 13, 2002
Selection of lymphocyte gating protocol has an impact on the level of reliability of T-cell subsets in aging specimensM Bergeron, J K A Nicholson, S Phaneuf, et al.
The Journal of Infectious Diseases|February 15, 2001
Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppressionJ B Angel, K G Parato, A Kumar, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Experimental Medicine|January 6, 1997
Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factorA D Badley, D Dockrell, M Simpson, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitorA A Pilon, J J Lum, J Sanchez-Dardon, et al.
Clinical Pharmacology and Therapeutics|March 16, 2007
Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survivalS R Vlahakis, G D Bren, A Algeciras-Schimnich, et al.
Journal of Virology|January 1, 1996
Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytesA D Badley, J A McElhinny, P J Leibson, et al.
HIV Clinical Trials|October 9, 2001
Comparative CD4 T-cell responses of reverse transcriptase inhibitor therapy with or without nelfinavir matched for viral exposureS Kravcik, A Magill, B Sanghvi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2001
Effect of cessation of highly active antiretroviral therapy during a discordant response: implications for scheduled therapeutic interruptionsN Hawley-Foss, G Mbisa, J J Lum, et al.
AIDS Research and Human Retroviruses|December 2, 1999
Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy numberD H Dockrell, A D Badley, A Algeciras-Schimnich, et al.
Frontiers in Bioscience : a Journal and Virtual Library|February 10, 2004
Antiretroviral therapy influences cellular susceptibility to apoptosis in vivoCurtis L Cooper, Barbara Phenix, Georgina Mbisa, et al.
Cytometry|July 13, 2002
Selection of lymphocyte gating protocol has an impact on the level of reliability of T-cell subsets in aging specimensM Bergeron, J K A Nicholson, S Phaneuf, et al.
The Journal of Infectious Diseases|February 15, 2001
Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppressionJ B Angel, K G Parato, A Kumar, et al.
Pageof 5